SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

SUVEN (SUVEN) News

Follow SUVEN (SUVEN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol SUVEN Asset market Sector Markets 90 days 1 Updated Sep 03, 2026, 09:19 AM UTC Open live news feed
L Suven Life Sciences completes enrollment in global Phase 3 masupirdine study Suven Life Sciences Ltd has completed patient enrollment in its global Phase 3 masupirdine study. EQUITY | Sep 03, 2026, 09:19 AM UTC